Is there a general autoantibody signature for cancer?

European Journal of Cancer

Volumn 48, Issue 15, 2012, Pages 2451-2461

  Ludwig, Nicole ^a   Keller, Andreas ^b   Leidinger, Petra ^a   Harz, Christian ^a   Backes, Christina ^a   Lenhof, Hans Peter ^b   Meese, Eckart ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Autoantibody profile; Cancer; Tumour immunology

Indexed keywords

ALPHA ENOLASE; ALPHA SYNUCLEIN; AUTOANTIBODY; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE I; CANCER AUTOANTIBODY; DIHYDROLIPOAMIDE DEHYDROGENASE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; INITIATION FACTOR 1; KINESIN 1; PYRUVATE KINASE; TETRASPANIN; UNCLASSIFIED DRUG; VIMENTIN; ZINC FINGER PROTEIN;

ACCURACY; ANTIBODY SCREENING; AREA UNDER THE CURVE; ARTICLE; BIOINFORMATICS; CANCER DIAGNOSIS; COHORT ANALYSIS; CONTROLLED STUDY; FALSE NEGATIVE RESULT; GLYCOLYSIS; HUMAN; HUMAN TISSUE; MOLECULAR CLONING; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE;

AUTOANTIBODIES; CASE-CONTROL STUDIES; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; NEOPLASMS; PRINCIPAL COMPONENT ANALYSIS; PROTEIN ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84866731679     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.01.017     Document Type: Article

References (46)

1. H.T. Tan, J. Low, S.G. Lim, and M.C. Chung Serum autoantibodies as biomarkers for early cancer detection FEBS J 276 23 2009 6880 6904
2. T. Soussi P53 Antibodies in the sera of patients with various types of cancer: a review Cancer Res 60 7 2000 1777 1788
3. J.A. Koziol, J.Y. Zhang, and C.A. Casiano Recursive partitioning as an approach to selection of immune markers for tumor diagnosis Clin Cancer Res 9 14 2003 5120 5126
4. X. Wang, J. Yu, and A. Sreekumar Autoantibody signatures in prostate cancer N Engl J Med 353 12 2005 1224 1235
5. F.M. Brichory, D.E. Misek, and A.M. Yim An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer Proc Nat Acad Sci U.S.A. 98 17 2001 9824 9829
6. C.J. Chapman, A. Murray, and J.E. McElveen Autoantibodies in lung cancer: possibilities for early detection and subsequent cure Thorax 63 3 2008 228 233
7. C.J. Chapman, A.J. Thorpe, and A. Murray Immunobiomarkers in small cell lung cancer: potential early cancer signals Clin Cancer Res 17 6 2010 1474 1480
8. G. Chen, X. Wang, and J. Yu Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma Cancer Res 67 7 2007 3461 3467
9. P. Leidinger, A. Keller, and S. Heisel Identification of lung cancer with high sensitivity and specificity by blood testing Respir Res 11 2010 18
10. P. Leidinger, A. Keller, and N. Ludwig Toward an early diagnosis of lung cancer: an autoantibody signature for squamous cell lung carcinoma Int J Cancer 123 7 2008 1631 1636
11. W.N. Rom, J.D. Goldberg, and D. Addrizzo-Harris Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers BMC Cancer 10 2010 234
12. L. Zhong, S.P. Coe, and A.J. Stromberg Profiling tumor-associated antibodies for early detection of non-small cell lung cancer J Thorac Oncol 1 6 2006 513 519
13. L. Zhong, G.E. Hidalgo, and A.J. Stromberg Using protein microarray as a diagnostic assay for non-small cell lung cancer Am J Respir Crit Care Med 172 10 2005 1308 1314
14. K.S. Anderson, S. Sibani, and G. Wallstrom Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer J Proteome Res 10 1 2010 85 96
15. C. Chapman, A. Murray, and J. Chakrabarti Autoantibodies in breast cancer: their use as an aid to early diagnosis Ann Oncol 18 5 2007 868 873
16. F. Fernandez-Madrid, N. Tang, and H. Alansari Autoantibodies to annexin XI-A and other autoantigens in the diagnosis of breast cancer Cancer Res 64 15 2004 5089 5096
17. L. Zhong, K. Ge, and J.C. Zu Autoantibodies as potential biomarkers for breast cancer Breast Cancer Res 10 3 2008 R40
18. M. Chatterjee, S. Mohapatra, and A. Ionan Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays Cancer Res 66 2 2006 1181 1190
19. A. Erkanli, D.D. Taylor, and D. Dean Application of Bayesian modeling of autologous antibody responses against ovarian tumor-associated antigens to cancer detection Cancer Res 66 3 2006 1792 1798
20. M.E. Hudson, I. Pozdnyakova, and K. Haines Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays Proc Nat Acad Sci U.S.A. 104 44 2007 17494 17499
21. Y. Ran, H. Hu, and Z. Zhou Profiling tumor-associated autoantibodies for the detection of colon cancer Clin Cancer Res 14 9 2008 2696 2700
22. B. Heubeck, O. Wendler, and K. Bumm Tumor-associated antigenic pattern in squamous cell carcinomas of the head and neck - analysed by SEREX Eur J Cancer 2006 Available from: http://dx.doi.org/10.1016/j.ejca2005.09.036
23. H.S. Lin, H.S. Talwar, and A.L. Tarca Autoantibody approach for serum-based detection of head and neck cancer Cancer Epidemiol Biomarkers Prev 16 11 2007 2396 2405
24. A. Keller, N. Ludwig, and N. Comtesse A minimally invasive multiple marker approach allows highly efficient detection of meningioma tumors BMC Bioinf 7 2006 539
25. N. Ludwig, A. Keller, and N. Comtesse Pattern of serum autoantibodies allows accurate distinction between a tumor and pathologies of the same organ Clin Cancer Res 14 15 2008 4767 4774
26. N. Ludwig, A. Keller, and S. Heisel Improving seroreactivity-based detection of glioma Neoplasia 11 12 2009 1383 1389
27. N. Ludwig, A. Keller, and S. Heisel Novel immunogenic antigens increase classification accuracy in meningioma to 93.84% Int J Cancer 128 6 2010 1493 1501
28. A. Keller, N. Comtesse, and N. Ludwig SePaCS-a web-based application for classification of seroreactivity profiles Nucleic Acids Res 35 Web Server issue 2007 W683 W687
29. M.D. Adams, M. Dubnick, and A.R. Kerlavage Sequence identification of 2,375 human brain genes Nature 355 6361 1992 632 634
30. K. Bussow, D. Cahill, and W. Nietfeld A method for global protein expression and antibody screening on high-density filters of an arrayed cDNA library Nucleic Acids Res 26 21 1998 5007 5008
31. R.D.C. Toam R: A language and environment for statistical computing 2009 R Foundation for Statistical Computing Vienna, Austria
32. H. Mann, and F. Wilcoxon On a test of whether one of two random variables is stochastically larger than the other Ann Mat Stat 18 1947 50 60
33. F. Wilcoxon Individual comparisons by ranking methods Biometric Bull 1 6 1945 80 83
34. Y. Bejamini, and Y. Hochberg Controlling the false discovery rate: a practical and powerful approach to multiple testing J R Stat Soc B 57 1995 289 300
35. C. Backes, A. Keller, and J. Kuentzer GeneTrail-advanced gene set enrichment analysis Nucleic Acids Res 35 Web Server issue 2007 W186 W192
36. M. Kanehisa, S. Goto, and Y. Sato KEGG for integration and interpretation of large-scale molecular data sets Nucleic Acids Res 40 1 2012 D109 D114
37. E.P. Diamandis Cancer biomarkers: can we turn recent failures into success? J Natl Cancer Inst 102 19 2010 1462 1467
38. M. Dabrowska, H. Grubek-Jaworska, and J. Domagala-Kulawik Diagnostic usefulness of selected tumor markers (CA125, CEA, CYFRA 21-1) in bronchoalveolar lavage fluid in patients with non-small cell lung cancer Pol Arch Med Wewn 111 6 2004 659 665
39. S. De Masi, M.E. Tosti, and A. Mele Screening for hepatocellular carcinoma Dig Liver Dis 37 4 2005 260 268
40. P.H. Gann, C.H. Hennekens, and M.J. Stampfer A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer JAMA 273 4 1995 289 294
41. S.M. Heisel, R. Ketter, and A. Keller Increased seroreactivity to glioma-expressed antigen 2 in brain tumor patients under radiation PLoS One 3 5 2008 e2164
42. C.P. Pallasch, A.K. Struss, and A. Munnia Autoantibodies against GLEA2 and PHF3 in glioblastoma: tumor-associated autoantibodies correlated with prolonged survival Int J Cancer 117 3 2005 456 459
43. P. Leidinger, A. Keller, and S. Heisel Novel autoantigens immunogenic in COPD patients Respir Res 10 2009 20
44. R.J. Paccione, H. Miyazaki, and V. Patel Keratin down-regulation in vimentin-positive cancer cells is reversible by vimentin RNA interference, which inhibits growth and motility Mol Cancer Ther 7 9 2008 2894 2903
45. V. Pancholi Multifunctional alpha-enolase: its role in diseases Cell Mol Life Sci 58 7 2001 902 920
46. B. Nolen, M. Winans, A. Marrangoni, and A. Lokshin Aberrant tumor-associated antigen autoantibody profiles in healthy controls detected by multiplex bead-based immunoassay J Immunol Methods 344 2 2009 116 120